- Last edited on February 7, 2022
Differences
This shows you the differences between two versions of the page.
Both sides previous revision Previous revision | Previous revision | ||
cl:psychiatric-side-effects-of-medications [on February 5, 2019] |
cl:psychiatric-side-effects-of-medications [on April 25, 2020] |
||
---|---|---|---|
Line 1: | Line 1: | ||
====== Psychiatric Side Effects of Medications and Substances ====== | ====== Psychiatric Side Effects of Medications and Substances ====== | ||
+ | {{INLINETOC}} | ||
===== Primer ===== | ===== Primer ===== | ||
Medications and recreational substances can have profound psychiatric symptoms for patients. | Medications and recreational substances can have profound psychiatric symptoms for patients. | ||
Line 6: | Line 7: | ||
* [[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181628/|Tango, R. C. (2003). Psychiatric side effects of medications prescribed in internal medicine. Dialogues in clinical neuroscience, 5(2), 155.]] | * [[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181628/|Tango, R. C. (2003). Psychiatric side effects of medications prescribed in internal medicine. Dialogues in clinical neuroscience, 5(2), 155.]] | ||
* [[https://jamanetwork.com/journals/jama/fullarticle/2684607|Qato, D. M., Ozenberger, K., & Olfson, M. (2018). Prevalence of Prescription Medications With Depression as a Potential Adverse Effect Among Adults in the United States. JAMA, 319(22), 2289-2298.]] | * [[https://jamanetwork.com/journals/jama/fullarticle/2684607|Qato, D. M., Ozenberger, K., & Olfson, M. (2018). Prevalence of Prescription Medications With Depression as a Potential Adverse Effect Among Adults in the United States. JAMA, 319(22), 2289-2298.]] | ||
+ | |||
===== Substance/Medication-Induced Major or Mild Neurocognitive Disorder ===== | ===== Substance/Medication-Induced Major or Mild Neurocognitive Disorder ===== |